analytics

By Dave Muoio 03:28 pm December 18, 2019
OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures. WHAT THEY DO OM1’s cloud platform employs AI machine learning organize and analyze large datasets for real-world measures of clinical...

Credit: Novartis

By Leontina Postelnicu 12:02 pm September 6, 2019
Home to around 40 museums, including Fondation Beyerel, Basel is famous for its vibrant art scene. But for the past 250 years, the country’s third largest city has also established itself as a hotspot for chemical and pharma innovation. It hosts the headquarters of two of the largest pharma companies in the world, Novartis and Roche. In fact, two predecessor companies of Novartis, Sandoz and Ciba...
By Dave Muoio 03:11 pm July 30, 2019
PhysIQ has received 510(k) clearance for an algorithm facilitating cloud-based analysis of patients’ continuous ambulatory respiration rates, according to an update to the FDA’s device clearance database that was confirmed by the company to MobiHealthNews. This regulatory clearance is the company’s third, and like its predecessors uses artificial intelligence to characterize raw sensor data as...
By Tammy Lovell 04:52 am March 20, 2019
Belfast-based data analytics company Diaceutics announced yesterday that it will seek listing on London’s junior stock exchange, the Alternative Investment Market (AIM). The firm, which serves the global pharmaceutical industry, plans to float on Thursday with an expected market capitalisation of around £53m ($70m). Diaceutics said in a press release that it has already raised £17m ($22.5m)...